CATALOGO DEI PRODOTTI DELLA RICERCA

TROMBETTA, Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.921
EU - Europa 5.834
AS - Asia 3.898
SA - Sud America 577
AF - Africa 128
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.373
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.784
RU - Federazione Russa 2.227
GB - Regno Unito 1.519
SG - Singapore 1.509
CN - Cina 1.072
IT - Italia 506
BR - Brasile 457
VN - Vietnam 410
HK - Hong Kong 302
DE - Germania 299
SE - Svezia 292
FR - Francia 252
FI - Finlandia 240
IE - Irlanda 203
KR - Corea 165
IN - India 87
CA - Canada 68
JP - Giappone 59
UA - Ucraina 56
MX - Messico 50
BD - Bangladesh 46
AR - Argentina 44
ID - Indonesia 44
NL - Olanda 44
PK - Pakistan 43
PL - Polonia 40
TR - Turchia 34
ZA - Sudafrica 27
AT - Austria 24
NG - Nigeria 24
IQ - Iraq 21
EC - Ecuador 20
BE - Belgio 19
ES - Italia 19
GR - Grecia 16
SA - Arabia Saudita 13
UZ - Uzbekistan 13
BJ - Benin 12
CO - Colombia 12
EG - Egitto 12
PY - Paraguay 12
CL - Cile 11
AU - Australia 10
CZ - Repubblica Ceca 10
DZ - Algeria 10
LT - Lituania 9
VE - Venezuela 9
GH - Ghana 8
JO - Giordania 8
PH - Filippine 8
IR - Iran 7
MA - Marocco 7
RO - Romania 7
TG - Togo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CR - Costa Rica 6
NO - Norvegia 6
BG - Bulgaria 5
CH - Svizzera 5
KG - Kirghizistan 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
DK - Danimarca 4
ET - Etiopia 4
HU - Ungheria 4
IL - Israele 4
KE - Kenya 4
LV - Lettonia 4
MY - Malesia 4
NP - Nepal 4
RS - Serbia 4
TH - Thailandia 4
TN - Tunisia 4
CY - Cipro 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LK - Sri Lanka 3
MD - Moldavia 3
PE - Perù 3
PT - Portogallo 3
AO - Angola 2
BY - Bielorussia 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
Totale 16.354
Salva come PNG Salva come JPEG
Città #
Southend 1.336
Ashburn 913
Dallas 847
Moscow 812
Singapore 746
Chandler 543
San Jose 504
Jacksonville 323
Hong Kong 295
Woodbridge 235
Verona 232
Beijing 228
Ann Arbor 208
Dublin 203
New York 183
Houston 163
The Dalles 140
Los Angeles 125
Ho Chi Minh City 120
Helsinki 91
Wilmington 84
Hanoi 80
Lawrence 78
Princeton 78
Jinan 67
Munich 66
Nanjing 54
Santa Clara 54
Seoul 52
Tokyo 50
Buffalo 46
Orem 45
Shenyang 45
Boardman 42
Turku 41
São Paulo 39
Milan 38
Dong Ket 36
Frankfurt am Main 36
Falkenstein 35
Redondo Beach 35
Warsaw 34
London 31
Sindelfingen 29
Tianjin 29
Council Bluffs 28
Hebei 26
Montreal 26
Redmond 26
Columbus 25
Bologna 24
Jakarta 24
Zhengzhou 24
Rio de Janeiro 22
Amsterdam 21
Denver 21
Nanchang 21
Phoenix 21
Chennai 20
Lancaster 20
Brussels 19
Haiphong 19
Romola 19
Hangzhou 18
Abuja 17
Brooklyn 17
Mianwali 17
Nuremberg 17
Stockholm 17
Taiyuan 16
Vienna 16
Brasília 15
Changsha 15
Dearborn 15
Haikou 15
Kent 15
Toronto 15
Atlanta 14
Boston 14
Chicago 14
Da Nang 14
Johannesburg 14
San Francisco 14
Shanghai 14
Washington 14
Redwood City 13
Tashkent 13
Cotonou 12
Dhaka 12
Hyderabad 12
Mexico City 12
Paris 12
Taizhou 12
Ankara 11
Dongguan 11
Guangzhou 11
Manchester 11
Poplar 11
Querétaro 11
Seattle 11
Totale 10.389
Salva come PNG Salva come JPEG
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 778
Common Variants Associated to Type 2 Diabetes in the Italian Population 491
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 243
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 225
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 222
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 218
Abstracts of 51st EASD Annual Meeting 218
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 randomized trial 214
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 214
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 213
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY. 210
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 208
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 208
Diabetic foot complicated by vertebral osteomyelitis and epidural abscess 207
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 205
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 203
Confronto delle variazioni acute della glicemia indotte dall'esercizio fisico aerobico o di forza muscolare: studio mediante holter glicemico 202
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 202
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 199
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 199
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 195
Assessement of 1th and snd phase of insulin secretion during OGTT and IVGTT 193
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 191
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 190
Aerobic and resistence exercise have different short-term effect on glucose levels in type 2 diabetes subject 190
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 190
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 189
Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans. 186
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 185
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 184
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication 183
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 179
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 178
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: Results from the RAED2 randomized trial - Note in: Riddell et al., Physical activity and exercise 178
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 177
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 177
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 177
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes 174
Beta-cell function across the spectrum of glucose tolerance in obese youth. 173
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 173
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 170
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 166
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 166
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 166
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 164
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 160
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 156
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 155
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 154
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 154
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 154
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 154
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes 153
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 153
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 153
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 153
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 152
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 150
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 150
Continuous Glucose Monitoring and Long-Term Assessment of Islet Function in Autologous Islet Transplantation after Total Pancreatectomy for Neoplasm: Preliminary Insights from a Prospective Study 144
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 144
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 141
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 140
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 136
A Randomized Crossover Trial Comparing Glucose Control During Postprandial Moderate Aerobic Activity and High-Intensity Interval Training in Adults With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 131
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 019 It's beta cell replacement time: 402 - Continuous glucose monitoring and assessment of islet function in autologous islet transplantation after total pancreatectomy for pancreatic neoplasia: preliminary data from the Verona cohort 131
Evaluating endothelial function of the common carotid artery: An in vivo human model. 131
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 128
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 127
Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study 126
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 123
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 122
Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report 122
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 121
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 121
Continuous subcutaneous insulin infusion in Italy: third national survey. 121
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes 121
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 119
Review article: type 2 diabetes and chronic liver disease in the Verona Diabetes Study 119
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 116
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 115
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes 114
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 113
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 113
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 113
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 112
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 111
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 111
Methods to assess in vivo insulin sensitivity and insulin secretion 110
61st EASD Annual Meeting of the European Association for the Study of Diabetes SO 077 Hi Hypo :) I would like to know you better 854 - Detecting hypoglycaemia with glycaemia risk index in adults with type 1 diabetes using continuous glucose monitoring and multiple daily injection therapy: a multicentric real-world study 107
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion 107
Variability of body weight, pulse pressure and glycemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. 106
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 104
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people 104
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 103
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire) 96
Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function 90
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire) 86
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study 83
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. 77
Totale 16.483
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.244
article - articoli 35.165
book - libri 0
conference - conferenze 13.704
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 375
Totale 98.488
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 0 0 0 0 39 65 82
2021/2022664 82 154 19 55 23 36 13 32 24 18 54 154
2022/20231.427 101 196 120 255 130 323 17 80 139 14 34 18
2023/20241.308 36 61 74 102 100 217 32 308 10 130 164 74
2024/20252.367 96 134 114 449 97 90 152 79 389 137 213 417
2025/20267.536 461 522 774 1.431 1.933 516 622 383 471 423 0 0
Totale 16.626